308
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Incidence of Venous Thromboembolism, Risk Factors and Prophylaxis in Hospitalized Patients in the South West Region of Cameroon

, , , , ORCID Icon &
Pages 317-324 | Published online: 22 Jul 2020

References

  • Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:381S–453S. doi:10.1378/chest.08-0656
  • Yusuf HR, Tsai J, Atrash HK, Boulet S, Grosse SD. Venous thromboembolism in adult hospitalizations –United States, 2007–2009. MMWR. 2012;61:401–404.
  • Danwang C, Temgoua MN, Agbor VN, Tankeu AT, Noubiap JJ. Epidemiology of venous thromboembolism in Africa: a systematic review. J Thromb Haemost. 2017;15:1770–1781. doi:10.1111/jth.13769
  • Kamdem F, Ngahane BHM, Hamadou B, et al. Epidemiology, clinical presentations and in-hospital mortality of venous thromboembolism at the douala general hospital: a cross-sectional study in Cameroon, Sub-Saharan Africa. World J Cardiovasc Dis. 2018;08:123–132. doi:10.4236/wjcd.2018.82012
  • Beckman MG, Hooper WC, Critchley SE, et al. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4):S495–501. doi:10.1016/j.amepre.2009.12.017
  • Baglin TP, White K, Charles A. Fatal pulmonary embolism in hospitalised medical patients. J Clin Pathol. 1997;50:609–610. doi:10.1136/jcp.50.7.609
  • Anderson F. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med. 1992;152(8):1660. doi:10.1001/archinte.1992.00400200092017
  • Anderson FA. Risk factors for venous thromboembolism. Circulation. 2003;107:9–16. doi:10.1161/01.CIR.0000078469.07362.E6
  • Hadi AG, sherif S, Alaa M, Mounir AR, George S. Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt. Thromb J. 2012;10:20. doi:10.1186/1477-9560-10-20
  • Bâ SA, Badiane S, Diop SN, et al. A cross-sectional evaluation of venous thromboembolism risk and use of venous thromboembolism prophylaxis in hospitalized patients in Senegal. Arch Cardiovasc Dis. 2011;104:493–501. doi:10.1016/j.acvd.2011.05.007
  • Kingue S, Bakilo L, Ze Minkande J, et al. Epidemiological African day for evaluation of patients at risk of venous thrombosis in acute hospital care settings: cardiovascular topic. Cardiovasc J Afr. 2014;25:159–164. doi:10.5830/CVJA-2014-025
  • Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism. Chest. 2004;126:338S–400S. doi:10.1378/chest.126.3_suppl.338S
  • Cohen AT, Tapson VF, Bergmann JF, et al. ENDORSE investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387–394. doi:10.1016/S0140-6736(08)60202-0
  • Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with enoxaparin study group. N Engl J Med. 1999;341:793–800. doi:10.1056/NEJM199909093411103
  • Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the international medical prevention registry on venous thromboembolism. Chest. 2007;132:936–945. doi:10.1378/chest.06-2993
  • Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practical guidelines. Chest. 2012;141:e227S. doi:10.1378/chest.11-2297
  • Delluc A, Montavon S, Canceil O, et al. Incidence of venous thromboembolism in psychiatric units. Thromb Res. 2012;130(6):e283–8. doi:10.1016/j.thromres.2012.10.002
  • White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90:446–455. doi:10.1160/TH03-03-0152
  • Sweetland S, Green J, Liu B, et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ. 2009;339:b4583. doi:10.1136/bmj.b4583
  • Mismetti P, Laporte-Simitsidis S, Tardy B, et al. Prevention of venous thromboembolism in internal medicine with unfractionated heparin or low-molecular weight heparins: a meta-analysis of randomized clinical trials. Thromb Haemost. 2000;83:14–19. doi:10.1055/s-0037-1613749
  • Kakkar AK, Davidson BL, Haas SK, et al. Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. J Thromb Haemost. 2004;2:221–227. doi:10.1111/j.1538-7933.2004.00588.x
  • Rashid ST, Thursz MR, Razvi NA, et al. Venous thromboprophylaxis in UK medical inpatients. J R Soc Med. 2005;98(11):507–512. doi:10.1177/014107680509801112
  • Rocha AT, Braga P, Ritt G, Lopes AA. Inadequacy of thromboprophylaxis in hospitalized medical patients. Rev Assoc Med Bras. 2006;52(6):441–446. doi:10.1590/S0104-42302006000600026
  • Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e278. doi:10.1378/chest.11-2404